Bayerscheringpharma.com (Text version)


Go to content
Service options
.
Contact us - Deutsche Version - Non-barrier-free application - Display options
Go to content
Current path
Bayer Schering Pharma / Therapeutic Areas / Therapeutic Areas A-Z / Breast cancer
Go to content
Navigation
Go to Start page - Go to Sitemap

Content

Breast cancer

Any woman can contract breast cancer. Almost 430,000 women suffer from a breast tumor in 2006 in Europe alone. Breast cancer thus accounts for 30 percent of all new cases of cancer reported. This makes breast cancer the most common form of cancer among women.

Prevention saves lives

Almost 131,900 women died of breast cancer in Europe in 2006. This is why medical check-ups are important, because early diagnosis improves the success rate of therapy and can save lives. In about one-in-five breast-cancer patients, metastases appear in the bones. Once cancer cells have settled there, the bone substance deteriorates. The consequences are not only severe pain in the bones, but also the disintegration or degeneration of the bone tissue (osteolysis). Furthermore, a dangerous surplus of calcium (hypercalcemia) can occur in the blood.

Studies offer new hope

Bayer Schering Pharma offers a product that helps reduce some of the symptoms that accompany cancer diseases, such as osteolysis and hypercalcemia. This drug has been helping patients for over two decades. New studies suggest that it can also delay the formation of metastases and thus prolong the patient's life.

Advice for patients
Every body reacts differently to medicines. Therefore it is impossible to tell which medicine works best for you. Please consult your physician.

Breast cancer
Our Therapeutic Areas

Click here for more information about this topic.


General Conditions of Use - Privacy Statement - Imprint